Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VANCAPP: Model-based Vancomycin Dosing in Infants
NCT04044703Phase 4Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Aug 2019
- Primary completion
- Dec 2020
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in sepsis, Bacteremia, bacterial infection, sponsored by Murdoch Children's Research Institute. Started Aug 2019; status: completed.
02
Drugs
vancomycin
03
Conditions
sepsisBacteremiabacterial infection
Beyond the preview
Go deeper on NCT04044703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04044703.